NOBILI, FLAVIO MARIANO
 Distribuzione geografica
Continente #
EU - Europa 50.024
AS - Asia 245
SA - Sud America 100
NA - Nord America 7
Totale 50.376
Nazione #
IT - Italia 50.019
CN - Cina 186
BR - Brasile 86
VN - Vietnam 33
SG - Singapore 19
US - Stati Uniti d'America 7
AR - Argentina 5
EC - Ecuador 3
UA - Ucraina 3
BD - Bangladesh 2
CO - Colombia 2
ID - Indonesia 2
PY - Paraguay 2
RU - Federazione Russa 2
CL - Cile 1
IQ - Iraq 1
KG - Kirghizistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 50.376
Città #
Genova 29.962
Genoa 11.863
Rapallo 4.593
Vado Ligure 3.484
Bordighera 110
Beijing 75
Ho Chi Minh City 13
Ashburn 7
Hanoi 7
São Paulo 7
Singapore 4
Belo Horizonte 3
Curitiba 3
Guarulhos 3
Franca 2
Milan 2
Phủ Lý 2
Ponta Grossa 2
Rio de Janeiro 2
Rome 2
Thái Nguyên 2
Vinnytsia 2
Angra dos Reis 1
Aracaju 1
Araraquara 1
As Samawah 1
Asunción 1
Bagé 1
Balneário Camboriú 1
Barbacena 1
Barra Bonita 1
Barra da Estiva 1
Barreiros 1
Bishkek 1
Biên Hòa 1
Boulogne Sur Mer 1
Brasília 1
Butiá 1
Campestre 1
Campinas 1
Campo Largo 1
Caracas 1
Carpina 1
Caruaru 1
Castilho 1
Chapadão do Sul 1
Criciúma 1
Cuiabá 1
Cunha 1
Cà Mau 1
Da Nang 1
Dhaka 1
Florianópolis 1
Formosa 1
Fortaleza 1
Goianésia 1
Grajaú 1
Gravataí 1
Guayaquil 1
Haiphong 1
Hải Dương 1
Iacanga 1
Indaiatuba 1
Isidro Casanova 1
Itaboraí 1
Juiz de Fora 1
Legnano 1
Loja 1
Lucas do Rio Verde 1
Macapá 1
Machala 1
Medellín 1
Mogi das Cruzes 1
Montes Claros 1
Natal 1
Niterói 1
Nova Lacerda 1
Nova Petrópolis 1
Novo Hamburgo 1
Osasco 1
Paraty 1
Passo Fundo 1
Passos 1
Paulista 1
Penaforte 1
Ponte Alta do Bom Jesus 1
Porto Feliz 1
Pouso Alegre 1
Presidente Getúlio 1
Quilpué 1
Quảng Ngãi 1
Resistencia 1
Ribeirão Preto 1
Rio das Ostras 1
Santana do Livramento 1
Santiago de Cali 1
Serra 1
Sierra Grande 1
Simferopol 1
São José do Rio Preto 1
Totale 50.228
Nome #
The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. 261
An updated Italian normative dataset for the Stroop color word test (SCWT) 217
A normative study of the Italian printed word version of the free and cued selective reminding test 199
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 190
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 182
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 178
Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease 174
Pulsatile electrical impedance response from cerebrally dead adult patients is not a reliable tool for detecting cerebral perfusion changes 173
99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease 173
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 172
Amyloid positron emission tomography and cognitive reserve. 172
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 172
Neuroimaging findings in mild cognitive impairment 170
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 168
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 164
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 162
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 162
A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience 161
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial 161
Psychological and social aspects in management of Alzheimer’s patients: an inquiry among caregivers. 160
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 157
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 157
A new frontier for amyloid PET imaging: multiple sclerosis 157
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 156
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 155
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 154
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 154
CORTICAL SOURCES OF RESTING EEG RHYTHMS IN MILD COGNITIVE IMPAIRMENT AND SUBJECTIVE MEMORY COMPLAINT. 153
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 153
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 152
Cortical sources of awake scalp EEG in eating disorders 151
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 151
Parkinson’s Disease Sleep Scale 2: application in an Italian population 151
Enhancement of SPECT Reconstructions by Means of Coregistered MR Data 150
Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer’s disease. A multicentric EEG study. 150
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 150
Cerebral Blood Flow and plasma free Tryptophan in cirrhotics with and without hepatic encephalopathy. 149
Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease 149
Fronto-parietal coupling of brain rhythms in mild cognitive impairment: A multicentric EEG study. 148
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 148
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 148
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 148
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia 148
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 147
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 147
Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study. 146
What predicts cognitive decline in de novo Parkinson's disease? 146
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 146
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment 145
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 145
ASSESSMENT OF DEMENTIA IN ETHNIC MINORITY PATIENTS IN EUROPE: A EUROPEAN ALZHEIMER'S DISEASE CONSORTIUM SURVEY. 144
123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study 144
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 144
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 144
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 144
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 143
Agomelatine Improves Apathy in Frontotemporal Dementia 143
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 143
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 142
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 142
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 142
Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders. 141
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 141
Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report 140
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 139
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 139
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 138
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium 138
Automatic Localization of the Hippocampal Region in MR Images to Asses Early Diagnosis of Alzheimer’s Disease in MCI Patients 138
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 137
Functional compensation in incipient Alzheimer's disease 137
Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management 137
A kinetics-based approach to amyloid PET semi-quantification 137
SPINAL CORD STIMULATION AND CEREBRAL HAEMODYNAMICS. 136
Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms 136
Cerebral Haemodynamic changes induced by spinal cord stimulation in man 136
HEMORHEOLOGICAL AND CEREBRAL BLOOD FLOW CHANGES INDUCED BY LDL- APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. 136
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 136
Early identification of MCI converting to AD: a FDG PET study 135
Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis 135
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 134
Phosphatidylserine: Quantitative eeg effects in healthy volunteers 134
Regional Cerebral Blood Flow in Essential Hypertension: data evaluation by a mapping system. 133
Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease 133
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 133
Regional Cerebral Blood Flow and Anxiety: a correlation study in neurologically normal patients. 132
TIMING OF DISEASE PROGRESSION BY QUANTITATIVE EEG IN ALZHEIMER’S PATIENTS 132
The role of the serotonergic system in REM sleep behavior disorder 132
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC 132
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 132
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 132
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 132
Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer’s disease. 131
Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease 131
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 131
Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study 131
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 130
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 130
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 129
Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome 129
Totale 14.902
Categoria #
all - tutte 181.777
article - articoli 161.179
book - libri 0
conference - conferenze 17.383
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.215
Totale 363.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.505 0 0 0 0 234 423 235 329 278 407 294 305
2021/20225.597 147 340 477 593 199 443 279 1.272 335 509 285 718
2022/20235.422 500 328 75 548 859 988 17 437 1.002 95 498 75
2023/20242.877 181 371 60 361 263 441 184 180 156 71 158 451
2024/20258.253 257 671 256 553 1.180 888 785 1.179 362 373 745 1.004
2025/20263.982 1.841 381 754 988 18 0 0 0 0 0 0 0
Totale 51.368